Insurance

Ryan Specialty shares rise on BMO upgrade and growth outlook

Article Image

Shares of Ryan Specialty (NYSE:RYAN) surged 3.9% to $66.64 in early trading today after BMO Capital Markets upgraded the insurance broker to "outperform" from "market perform."

BMO also raised its price target for the stock to $75 from $65, representing a 17% upside from its last close.

The upgrade comes as BMO highlighted Ryan Specialty’s ongoing investments in shifting work processes to lower-cost geographies and acquiring high-margin businesses.

The brokerage noted that these efforts, along with double-digit organic growth, provide a solid foundation for margin expansion in the coming quarters.

BMO pointed to the success of Ryan Specialty's peers, such as Arthur J. Gallagher (NYSE:AJG), which has more than 20% of its workforce in India, as a key driver of margin improvement through geographic cost restructuring.

According to LSEG data, six out of 15 brokerages rate Ryan Specialty as a "buy" or higher, eight rate it as "hold," and one suggests "sell," with a median price target of $68.50.

As of the last close, Ryan Specialty's share price was up 49.7% year-to-date.

Disclaimer
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.
Publisher
Grafa